Patents Assigned to University
  • Patent number: 10439292
    Abstract: Electromagnetic shielding systems, apparatuses, and method are provided. One apparatus is an example free-space absorber metamaterial that includes a first array of patches disposed at a first plane, a conductive backplane disposed at a structural surface plane, and a first dielectric spacer disposed between the first array of patches and the conductive backplane. A first bandwidth of absorption for the free-space absorber metamaterial may be based on the area of a patch in the first array of patches, the first electrical resistance of a patch in the first array of patches, and the first gap distance taken between the first array of patches and the conductive backplane.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 8, 2019
    Assignee: The Johns Hopkins University
    Inventors: Kenneth R. Grossman, Joseph A. Miragliotta, Adam J. Maisano, Douglas B. Trigg, Steven M. Storck
  • Patent number: 10434116
    Abstract: The present invention provides methods for treating a coronavirus infection. For example, treatment may be effected by administering a neurotransmitter inhibitor, a signaling kinase inhibitor, an estrogen receptor inhibitor, a DNA metabolism inhibitor or an anti-parasitic agent. Also provided are methods for treating a coronavirus infection in which an anti-viral drug also is administered during any of the described methods.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: October 8, 2019
    Assignees: University of Maryland, Baltimore, United States Government as represented by the Secretary, Department of Health and Human Services
    Inventors: Matthew Frieman, Peter B. Jarhling, Lisa E. Hensley
  • Patent number: 10436791
    Abstract: Gold nanoparticles functionalized with thiolated, bidentate Schiff base ligands. The Schiff base ligands form a ligand monolayer surrounding and binding to the surface of a gold nanoparticle core through Au—S linkages. The functionalized gold nanoparticle composites have a spherical shape, an average diameter of 7-15 nm and a narrow particle size distribution. Methods of assessing these functionalized gold nanoparticle composites as fluorescent probes in Fe(III) chemosensing applications, methods of preparing the functionalized gold nanoparticle composites and methods of detecting Fe(III) ions with the same are also provided.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: October 8, 2019
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Mohammed Nasiruzzaman Shaikh, Aasif Helal, Abiola Azeez Jimoh
  • Patent number: 10435814
    Abstract: A single-crystalline metal is created on a substrate by liquefying a metal material contained within a crucible while in contact with a surface of the substrate, cooling the metal material by causing a temperature gradient effected in the substrate in a direction that is neutral along the surface of the substrate and, therein, growing the single-crystalline metal in the crucible.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: October 8, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James D. Plummer, Kai Zhang, Xue Bai Pitner, Jonathan A. Fan
  • Patent number: 10436925
    Abstract: Aspects of the disclosure provide a method for processing three-dimensional (3D) hexagonally sampled seismic data. The method can include receiving 3D hexagonally sampled seismic data represented using 3D spiral architecture (SA), the 3D hexagonally sampled seismic data including a plurality of data traces each corresponding to center of a hexagon in the 3D SA, representing the 3D hexagonally sampled seismic data as two-dimensional (2D) seismic data using spiral architecture (SA) addressing scheme, and processing the 2D seismic data with an SA based signal processing process.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: October 8, 2019
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Wail A. Mousa, Haroon Ashraf
  • Patent number: 10437702
    Abstract: The present invention is directed to a method for diagnosing faults in a software system, according to which, predictions of the probability of each software component of the software system to be faulty are obtained from a diagnoser, and the probability predictions are input to a fault diagnosis software module, executed by the diagnoser.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: October 8, 2019
    Assignee: B. G. Negev Technologies and Applications Ltd., at Ben-Gurion University
    Inventors: Meir Kalech, Ron Zvi Stern, Amir Elmishali
  • Patent number: 10435717
    Abstract: The present invention provides genetically modified eukaryotic host cells that produce isoprenoid precursors or isoprenoid compounds. A subject genetically modified host cell comprises increased activity levels of one or more of mevalonate pathway enzymes, increased levels of prenyltransferase activity, and decreased levels of squalene synthase activity. Methods are provided for the production of an isoprenoid compound or an isoprenoid precursor in a subject genetically modified eukaryotic host cell. The methods generally involve culturing a subject genetically modified host cell under conditions that promote production of high levels of an isoprenoid or isoprenoid precursor compound.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: October 8, 2019
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, James Kirby, Eric M. Paradise
  • Patent number: 10434221
    Abstract: Biodegradable antimicrobial films are provided that are solid at room temperature and substantially liquefy in situ after implantation into a mammal, such as a human patient. Methods of using the films to cover a medical device, such as a breast implant, prior to insertion into a subject are also provided.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: October 8, 2019
    Assignee: Board of Regents, The University of Texas System
    Inventors: Joel Rosenblatt, Issam Raad, Andrew P. Dennis
  • Patent number: 10435712
    Abstract: The present invention relates to the discovery of a high titer hybrid-virus vector that gives rise to high titer virus like vesicles (VLVs) that can be used as a vaccine. The invention includes compositions and methods of generating an evolved hybrid-virus vector vaccine and selecting high titer VLVs, methods of treating and/or preventing or immunizing against, a specific disease or disorder, and methods of inducing a memory T cell and B cell immune response in a subject administered the VLV composition produced thereby. Furthermore, the invention encompasses a pharmaceutical composition for vaccinating a subject as well as a high titer protein expression system.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: October 8, 2019
    Assignee: Yale University
    Inventors: John Rose, Nina Rose
  • Patent number: 10434327
    Abstract: Various systems and methods are implemented for in vivo use in a living animal. One such method involves stimulating target cells having light-responsive proteins and includes providing an elongated light-delivery structure in a narrow passageway in the animal, the elongated light-delivery structure having separately-activatable light sources located along the length of the elongated light-delivery structure. The method also includes activating less than all the light sources to deliver light to light-responsive proteins adjacent to the activated light sources along the length of the elongated light-delivery structure, thereby stimulating target cells in vivo.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: October 8, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Karl Deisseroth, M. Bret Schneider
  • Patent number: 10435682
    Abstract: The invention relates to compositions comprising arginine deiminase and their use in a method of reducing aggregation of disordered protein in a subject.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: October 8, 2019
    Assignee: University of South Florida
    Inventors: Daniel C. Lee, Kevin Ron Nash
  • Patent number: 10434213
    Abstract: Provided herein are keratin compositions (e.g., keratin gels, scaffolds, particulates, and the like) including a compound of interest, useful for release and/or delivery of the compound of interest (e.g., in vivo or in vitro). In some embodiments, the composition is a composition formulated for controlled release of the compound of interest.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: October 8, 2019
    Assignee: Wake Forest University Health Sciences
    Inventors: Mark E. Van Dyke, Justin M. Saul, Thomas L. Smith, Roche de Guzman
  • Patent number: 10437572
    Abstract: Methods, systems, and computer readable media for compiling concise expressive design patterns within computer software source code are described. Some implementations can include methods and systems that resolve some problems of implementing design patterns in an OO and/or AO program. The disclosed technique facilitates writing programs that apply design patterns to its structure and behavior, in an easy manner. Some programming language constructs (associated with new keywords, syntax, and semantics) are disclosed that convey the goal of some design patterns in order to allow programmers to implement design patterns simply and concisely. These constructs are added as extensions to a compiler and a compiler-based approach to concise expressive design pattern source code is described.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: October 8, 2019
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Taher Ahmed Ghaleb, Khalid Abdullah Aljasser, Musab A. Alturki
  • Patent number: 10434164
    Abstract: Compositions and methods are provided that enable activation of innate immune responses through RIG-I like receptor signaling. The compositions and methods incorporate synthetic nucleic acid pathogen associated molecular patterns (PAMPs) that comprise elements initially characterized in, and derived from, the hepatitis C virus genome.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: October 8, 2019
    Assignee: University of Washington through its Center for Commercialization
    Inventors: Michael J. Gale, Jr., Gretja Schnell, Yueh-Ming Loo
  • Patent number: 10435367
    Abstract: Indirubin is the major active anti-tumor component of a traditional Chinese herbal medicine used for treatment of chronic myelogenous leukemia (CML). Indirubin derivatives (IRDs) potently reduce the viabilities of various cancer cells and affect kinase activities. IRDs disclosed herein provide new therapeutics for cancer and conditions regulated by the kinase activities.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: October 8, 2019
    Assignees: City of Hope, The National and Kapodistrian University of Athens
    Inventors: Sangkil Nam, Richard Jove, Leandros Skaltsounis
  • Patent number: 10436623
    Abstract: The measuring cup includes numerous embodiments configured for a user to precisely determine the cup contents without need to lift the cup to one's eye level or to lower the eye level to the level of the cup contents. The various embodiments include folding cups; cups having transparent passages in the wall; cups having adjustably positionable bottoms; cups having level indicator rods in the cup interior extending upward from the cup bottom; cups having one or more filaments extending across the cup interior; cups having rigid level indicators spanning the cup interior; cups having adjustably positionable level indicator tabs therein; cups having buoyant level indicator tabs adjustably positionable in the cup interior; and cups having removable clip-on scales extending down along the interior of the cup wall, the scales having a plurality of attachment points for the removable attachment of a level indicator tab at a desired attachment point.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: October 8, 2019
    Assignee: King Saud University
    Inventors: Mohd Aftab Alam, Fahad Ibrahim Al-Jenoobi, Abdullah M. Al-Mohizea
  • Patent number: 10439228
    Abstract: Provided is a method for forming noble metal nanoparticles on a support. In particular, the method includes heating precursors of the noble metal nanoparticles in a spiral glass tube reactor to reduce the precursors to form the noble metal nanoparticles on the support.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: October 8, 2019
    Assignee: Nanyang Technological University
    Inventors: Weijiang Zhou, Miao Li, Siew Hwa Chan
  • Patent number: 10434152
    Abstract: Antigenic polypeptides of the growth factor receptor HER2, for breaking the tolerance of a host against self HER2. The antigenic polypeptides include HER2 polypeptides with single amino acid substitutions of lysine for glutamine, arginine for glutamine, or aspartic acid for asparagine. Gene expression constructs, vaccine compositions, and immunization methods including the substituted HER2 polypeptides. Methods for immunizing mammalian subjects with heterologous unsubstituted HER2 antigenic polypeptides, including polypeptides of feline and bear HER2. A diagnostic method of determining whether a mammalian subject is sufficiently immunocompetent to respond to immunotherapies directed at breaking tolerance to self HER2.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: October 8, 2019
    Assignee: Wayne State University
    Inventors: Wei-Zen Wei, Heather Gibson, Richard Jones, Joyce Reyes
  • Patent number: 10437945
    Abstract: Systems and methods for predicting order-of-magnitude viral cascades in social networks are disclosed.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: October 8, 2019
    Assignee: Arizona Board of Regents on Behalf of Arizona State University
    Inventors: Paulo Shakarian, Ruocheng Guo, Elham Shaabani, Abhinav Bhatnagar
  • Patent number: 10435418
    Abstract: A reaction method comprising combining a carbonyl-substituted arylboronic acid or ester and an ?-effect amine in aqueous solution at a temperature between about ?5 C to 55 C, and a pH between 2 and 8 to produce an adduct. A process is also provided comprising: contacting a boron compound having a boron atom bonded to a sp2 hybridized carbon conjugated with a cis-carbonyl, the boron having at least one labile substituent, with an ?-effect amine, in a solvent for a time sufficient to form an adduct, which may proceed to further products.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: October 8, 2019
    Assignee: The Research Foundation for the State University o
    Inventors: Susan Bane Tuttle, Ozlem Dilek, Kamalika Mukherjee